Chicken infectious bursal virus detection kit and its application

By using HMB-VP2 recombinant protein and chemiluminescence ELISA technology, a high sensitivity and strong specificity chicken infectious bursvar detection kit was developed, which solved the problems of low detection sensitivity and poor specificity in the prior art, and achieved the Accurate detection and prevention of chicken infectious bursal virus.

CN118028325BActive Publication Date: 2024-11-26BEIJING YISEN BIOTECH
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410165165.8
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2024-02-05
Publication Date
2024-11-26
Estimated Expiration
2044-02-05

AI Technical Summary

Technical Problem

The existing chicken infectious bursal virus detection technology has problems such as low sensitivity, poor specificity, complex operation and high cost. In particular, commercial ELISA kits are prone to false positives and are not sensitive to low-concentration antibody detection. Causes some infected animals to miss the test.

Method used

Using HMB-VP2 recombinant protein as the coated antigen, a VP2 protein with a high expression volume and structure similar to that of a natural protein was obtained through the baculovirus expression system. Combined with chemiluminescent ELISA technology, a more accurate, sensitive and specific detection kit was developed.

Benefits of technology

Accurate detection of infectious bursfari virus infection of chickens has been achieved, the detection efficiency and accuracy have been improved, the false positive rate has been reduced, and it can be effectively tested at a lower antibody concentration, which has important prevention and control significance.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0004699504560000101
    Figure BDA0004699504560000101
  • Figure BDA0004699504560000111
    Figure BDA0004699504560000111
  • Figure BDA0004699504560000112
    Figure BDA0004699504560000112
Patent Text Reader

Abstract

The present invention relates to the field of biological detection technology, and in particular to a chicken infectious bursal disease virus detection kit and application. The antigen protein coated in the kit of the present invention is HMB-VP2 recombinant protein, which is obtained by gene expression of the nucleotide sequence shown in SEQ ID NO.1. The kit and detection method obtained by using the HMB-VP2 recombinant protein can accurately detect VP2 protein antibodies produced by chicken infectious bursal disease virus infection, and judge whether the tested animal is infected with chicken infectious bursal disease virus. It has the advantages of good sensitivity, specificity and stability, and is of great significance to the prevention and control of chicken infectious bursal disease and the development of animal husbandry.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of biological detection, and in particular to a chicken infectious bursal virus detection kit and application thereof. Background Art

[0002] Infectious bursal disease (IBD) is a highly contagious disease of chickens caused by infectious bursal disease virus (IBDV). IBDV belongs to the genus Avian Double-stranded RNA virus of the family BisRNA Viridae. Its genome contains two linear double-stranded RNAs, A and B. IBDV-A contains two open reading frames (ORFs), ORF1 and ORF2. ORF1 encodes a polyprotein pVP2-VP3-VP4, which can be hydrolyzed into the precursor pVP2 of VP2 protein, the structural protein VP3 and the non-structural protein VP4. Among them, the pVP2 protein is hydrolyzed into the mature VP2 protein by the VP4 protease. ORF2 encodes the non-structural protein VP5 of IBDV. IBDV-B encodes the VP1 protein. The VP2 protein is the main host protective antigen and is closely related to the induction of virus neutralizing antibodies, virulence variation and cell apoptosis. IBD damages the lymphocytes of the bursal follicle of chickens, reduces the level of immune response in chickens, and causes immunosuppression and immune failure of various vaccines. Chicks that survive the disease may suffer from permanent immunosuppression, and the production performance of affected flocks usually decreases. For many years, IBD has been a serious problem facing the poultry industry, causing huge economic impact on the poultry industry.

[0003] Prevention of IBD requires strict hygiene measures and vaccine prevention, and rapid detection of IBDV plays a key role in promoting early prevention and control. Existing IBDV diagnostic technologies include clinical diagnosis and laboratory diagnosis. Clinical diagnosis is mainly based on the clinical symptoms and pathological changes of diseased chickens, which are mainly manifested as listlessness and ruffled feathers; the excrement is mostly white and watery. The bursa of dead chickens is edematous and accompanied by bleeding, organomegaly, and bleeding spots on the pectoral muscles. This method can only be used as a preliminary judgment, and further diagnosis still needs to rely on laboratory diagnosis. Laboratory diagnosis includes molecular biology diagnosis and immunology diagnosis. Among them, molecular biology diagnosis includes reverse transcription PCR technology, fluorescence quantitative PCR technology, gene chip technology, etc. Immunology diagnosis includes agar diffusion test, immunofluorescence test, virus neutralization test, immune colloidal gold detection technology, enzyme-linked immunosorbent assay, etc. Molecular biology diagnostic methods mainly detect the genomic nucleic acid level of the virus. Molecular biology detection methods are highly sensitive and specific, but they are time-consuming, the equipment used is expensive, and the requirements for operators are high, which is not suitable for detection in farms. The agar gel diffusion test is a test that combines soluble antigens with corresponding antibodies in 1% agar gel containing electrolytes to form a white flocculent precipitate. This method is simple to operate and low in cost, but the detection time is long and the sensitivity is low. Immunofluorescence technology specifically combines the antigen to be tested with the fluorescently labeled antibody and observes under a fluorescence microscope to diagnose the virus. The operation steps of this technology are complicated, there are non-specific staining problems, and it is easy to cause false positives. Immunocolloidal gold detection technology has fast detection speed and simple operation. The disadvantage is that it has high requirements for the purity and concentration of the labeled protein, and false positives are prone to occur. The principle of enzyme-linked immunosorbent assay is to absorb antibodies or antigens on a solid phase carrier by physical methods, and then perform immunoenzyme determination. Because this method has the advantages of simple operation, fast detection speed and strong specificity, it has been widely used in the detection and diagnosis of most animal infectious diseases. There are commercial ELISA kits for detecting antibody types on the market. Most IBDV ELISA antibody detection kits use IBDV whole virus packages for coating. There will be cross-reactions between IBDV and pestivirus members, so the use of IBDV whole virus for coating will result in poor specificity of the test results, prone to false positives, and low accuracy. For those animals that have been infected, since the infected individuals have neutralizing antibodies, the virus replicates very slowly, resulting in very low antibody concentrations in the body, and the commercial ELISA kits have low sensitivity, making it difficult to detect these low concentrations of antibodies, which will lead to missed detection of some infected animals.

[0004] In view of this, the present invention is proposed. Summary of the invention

[0005] In view of the technical problems existing in the background technology, the present invention provides a chicken infectious bursal virus detection kit and application.

[0006] Specifically, the technical solution provided by the present invention is as follows:

[0007] In a first aspect, the present invention provides the use of HMB-VP2 recombinant protein in preparing a chicken infectious bursal virus detection kit, wherein the HMB-VP2 recombinant protein is obtained by gene expression of the nucleotide sequence shown in SEQ ID NO.1.

[0008] The nucleotide sequence shown in SEQ ID NO.1 of the present invention includes the bee pollen signal peptide gene HMB and the VP2 gene. VP2 is the main structural protein of IBDV and is one of the main factors causing cell apoptosis after cells are infected with IBDV. It carries a protective neutralizing antigenic site of IBDV that depends on the three-dimensional conformation of the protein and can induce the production of protective neutralizing antibodies. At the same time, the addition of the bee pollen peptide expression tag HMD helps to increase the expression amount of the target protein, and the structure and biological activity of the expression product are more similar to the natural protein.

[0009] Preferably, the chicken infectious bursal virus detection kit of the present invention is a chemiluminescent ELISA antibody detection kit, comprising a coating solution, wherein the coating solution uses a carbonate buffer solution with a pH value of 9.2-9.8 as a base solvent, and the added antigen is 0.9-1.1 μg / ml of HMB-VP2 recombinant protein.

[0010] More preferably, the coating solution uses carbonate buffer with a pH value of 9.6 as the base solvent, and the added antigen is 1.0 μg / ml HMB-VP2 recombinant protein. 1 μg / ml antigen coating concentration has the best effect on the light index and signal-to-noise ratio in subsequent optical detection.

[0011] The application of the HMB-VP2 recombinant protein provided by the present invention in a chemiluminescent ELISA antibody detection kit, and the chemiluminescent ELISA antibody detection kit and method established by using the HMB-VP2 recombinant protein of the present invention as a coating protein, have better accuracy, sensitivity, specificity and detection efficiency, and are of great significance for preventing and controlling the occurrence and prevalence of infectious bursal disease in chickens.

[0012] Preferably, the HMB-VP2 recombinant protein of the present invention is obtained by expressing the gene of the nucleotide sequence shown in SEQ ID NO.1 through a baculovirus expression system. The baculovirus expression system has a high expression amount of HMB-VP2 recombinant protein, and the structure and biological activity of the expression product are more similar to the natural protein. The present invention selects a baculovirus system carrying a His expression tag, and expresses the target protein in sf9 cells, and finally obtains a HMB-VP2 recombinant protein with good solubility, high concentration and good reactogenicity.

[0013] In a more specific embodiment provided by the present invention, the HMB-VP2 recombinant protein is obtained by cloning the bee venom signal peptide gene (HMB) and the VP2 gene into the pFastbac1 expression vector, respectively, and transforming them into the host bacterium E.coliJM10. Then, after polymerase chain reaction, double enzyme digestion and gene sequence identification, a recombinant plasmid is obtained. Subsequently, the recombinant plasmid is transformed into DH10Bac competent cells, and a recombinant bacmid containing bee venom signal peptide and IBDV VP2 is obtained by blue-white screening and PCR identification. The recombinant bacmid is transfected into sf9 cells, and a recombinant baculovirus is constructed after transposition. The recombinant baculovirus infects sf9, and the expressed recombinant protein is identified by SDS-PAGE and Western-blot. The recombinant VP2 protein is purified by nickel column affinity chromatography. As a result, the target protein is secreted and expressed, and the expression amount of VP2 protein is increased. The VP2 protein is coated on a chemiluminescent plate, and the recombinant VP2 protein is tested for biological activity by a chemiluminescent enzyme-linked immunosorbent assay, and the results show that the sensitivity and specificity of the recombinant VP2 protein are good.

[0014] The HMB-VP2 recombinant protein obtained by the present invention provides a new theoretical basis and technical support for the development of IBDV prevention and treatment and diagnostic reagents. The purified HMB-VP2 recombinant protein can be used to establish a chemiluminescent ELISA detection kit and a detection method.

[0015] In a second aspect, the present invention provides a detection kit, comprising a coating solution, wherein the coating solution uses a carbonate buffer with a pH value of 9.2-9.8 as a base solvent, and the added antigen is 0.9-1.1 μg / ml of HMB-VP2 recombinant protein; preferably, the coating solution uses a carbonate buffer with a pH value of 9.6 as a base solvent, and the added antigen is 1.0 μg / ml of HMB-VP2 recombinant protein; the HMB-VP2 recombinant protein is obtained by gene expression of the nucleotide sequence shown in SEQ ID NO.1.

[0016] Preferably, the detection kit further comprises one or more of an antigen-coated plate, an enzyme-labeled secondary antibody, a sample diluent, a positive control serum, a negative control serum, a luminescent substrate and a washing solution.

[0017] The present invention utilizes the coated antigen and the microplate kit prepared based on the chemiluminescent immunoassay method can perform detection more accurately, more sensitively and more efficiently, which is of great significance for preventing and controlling the infection and epidemic of infectious bursal disease virus of chickens.

[0018] Preferably, the enzyme-labeled secondary antibody of the present invention is preferably a secondary antibody labeled with horseradish peroxidase. In a preferred embodiment of the present invention, the enzyme-labeled secondary antibody is a goat anti-chicken IgG antibody labeled with horseradish peroxidase. The enzyme-labeled secondary antibody is preferably diluted 10,000 times with 5% BSA-PBST when used.

[0019] Preferably, the sample diluent of the present invention is a phosphate buffer containing casein and Tween-20; based on the volume of the phosphate buffer being 100 vol%, the casein content is preferably 4-6 vol%, more preferably 5 vol%; the Tween-20 content is preferably 0.4-0.6 vol%, more preferably 0.5 vol%. The present invention does not specifically limit the specific sources of the casein and the Tween-20, and any conventional commercially available product in the art may be used.

[0020] Preferably, the luminescent substrate of the present invention comprises a luminescent substrate A and a luminescent substrate B; the luminescent substrate A is based on a Tris buffer solution with a pH value of 7.5-8.5 and a concentration of 0.04-0.06 mol / L, and is added with 0.08-0.12 mmol / L of luminol and 0.08-0.12 g / L of hydroxycoumarin; the luminescent substrate B is based on an ammonium acetate solution with a pH value of 5.0-5.5 and a concentration of 0.04-0.06 mol / L, and is added with 0.06-0.08 mmol / L of vitamin C and 2.7-3.3 mmol / L of amino acid oxidase. More preferably, the luminescent substrate A uses Tris buffer with a pH value of 8.0 and a concentration of 0.05 mol / L as the base solvent, and adds 0.1 mmol / L luminol and 0.1 g / L hydroxycoumarin; the luminescent substrate B uses ammonium acetate solution with a pH value of 5.2 and a concentration of 0.05 mol / L as the base solvent, and adds 0.07 mmol / L vitamin C and 3.0 mmol / L amino acid oxidase.

[0021] Preferably, the washing solution of the present invention comprises 0.018-0.022 mol / L of sodium dihydrogen phosphate, 0.07-0.09 mol / L of sodium dihydrogen phosphate, 1.29-1.45 mol / L of sodium chloride and 0.4-0.6 vol% of Tween-20 based on a 10-fold concentration; more preferably, the washing solution comprises 0.02 mol / L of sodium dihydrogen phosphate, 0.08 mol / L of sodium dihydrogen phosphate, 1.37 mol / L of sodium chloride and 0.5 vol% of Tween-20 based on a 10-fold concentration; the pH value of the washing solution is preferably 7.3-7.5, more preferably 7.4 based on a 10-fold concentration.

[0022] In a third aspect, the present invention also provides the use of the detection kit in the detection of infectious bursal disease virus for non-disease diagnosis purposes, and the application includes detecting whether vaccine products, blood products or poultry processed products contain infectious bursal disease virus.

[0023] Preferably, the application comprises the following steps:

[0024] S1. After the sample is diluted with sample diluent, it is added to the coated plate for reaction;

[0025] S2, washing the coated plate after the reaction in step S1 with a washing solution, adding an enzyme-labeled secondary antibody, and incubating;

[0026] S3, washing the coated plate after incubation in step S2 with a washing solution, adding a luminescent substrate, and detecting the luminescence value using a chemiluminescent immunoassay detection instrument;

[0027] S4, judging whether the test sample contains infectious bursal virus of chicken according to the luminescence value obtained in step S3;

[0028] Among them, the dilution multiple described in step S1 is preferably 100-fold dilution. The 100-fold diluted sample has the best effect in the light index and signal-to-noise ratio performance in subsequent optical detection. The temperature of the reaction in step S1 is preferably 36-38°C, more preferably 37°C; the reaction time is preferably 10-30min, more preferably 15-20min, more preferably 15min. The incubation temperature in step S2 is preferably 36-38°C, more preferably 37°C; the incubation time is preferably 10-30min, more preferably 15-20min, more preferably 15min. The reaction temperature after adding the luminescent substrate in step S3 is preferably 15-25°C; the reaction time is preferably 5-6min, more preferably 5min; after the reaction is completed, the luminescence value is detected using a chemiluminescence immunoassay detection instrument.

[0029] The determination method in step S4 includes:

[0030] The S / P value was calculated according to the formula: S / P value = (luminescence value of the test sample - luminescence value of the negative control serum sample) / (luminescence value of the positive control serum sample - luminescence value of the negative control serum sample);

[0031] If the S / P value is less than 0.45, it is determined that the sample does not contain infectious bursal disease virus; if the S / P value is ≥ 0.45, it is determined that the sample contains infectious bursal disease virus.

[0032] Beneficial effects:

[0033] The present invention provides a chicken infectious bursal disease virus detection kit and application. The antigen protein coated in the kit is a HMB-VP2 recombinant protein, which is obtained by gene expression of the nucleotide sequence shown in SEQ ID NO.1. The nucleotide sequence shown in SEQ ID NO.1 of the present invention includes a bee pollen signal peptide gene HMB and a VP2 gene. VP2 is the main structural protein of IBDV, which carries a protective neutralizing antigenic site of IBDV that depends on the three-dimensional conformation of the protein and can induce the production of protective neutralizing antibodies. At the same time, the addition of the bee pollen peptide expression tag HMD helps to increase the expression amount of the target protein, and the structure and biological activity of the expression product are more similar to the natural protein. The kit and the detection method obtained by using the HMB-VP2 recombinant protein can accurately detect the VP2 protein antibodies produced by chicken infectious bursal disease virus infection, and judge whether the tested animal is infected with chicken infectious bursal disease virus. It has the advantages of good sensitivity, specificity and stability, and is of great significance to the prevention and control of chicken infectious bursal disease and the development of animal husbandry. DETAILED DESCRIPTION

[0034] The technical solutions provided by the present invention are described in detail below in conjunction with the examples, but they should not be understood as limiting the scope of protection of the present invention. Unless otherwise specified, the experimental methods used in the examples are conventional methods; the materials and reagents used can be obtained from commercial sources.

[0035] Example 1

[0036] The present embodiment provides a chemiluminescent ELISA antibody detection kit for chicken infectious bursal virus, which includes a chemiluminescent antigen coated plate, an enzyme-labeled antibody, a serum diluent, a positive control serum, a negative control serum, a luminescent substrate A, a luminescent substrate B and a 10-fold concentrated washing solution.

[0037] (1) The chemiluminescent antigen-coated plate is a milky white opaque polystyrene 96-well plate, which is coated with the VP2 protein of infectious bursal disease virus of chickens. The coating process is as follows: add the VP2 protein of infectious bursal disease virus of chickens to a carbonate buffer solution with a pH of 9.6, so that the concentration of the VP2 protein is 1ug / mL, and add the protein coating solution to the chemiluminescent plate at a volume of 100uL / well. Incubate at 2-8℃ for 16-18h; shake off the protein coating solution in the chemiluminescent plate, add 150uL / well of 5% BSA-PBST to each well for blocking, and block at 37℃ for 2h; shake off the blocking solution in the chemiluminescent plate, dry at 25℃ for 2h, put in a desiccant, seal and package, and store at 2-8℃;

[0038] (2) The VP2 protein is a recombinant protein, which is obtained by cloning the bee venom signal peptide gene (HMB) and the VP2 gene into the pFastbac1 expression vector, respectively, and transforming them into the host bacterium E. coli JM10. Then, the recombinant plasmid is obtained by polymerase chain reaction, double enzyme digestion and gene sequence identification. The recombinant plasmid is then transformed into DH10Bac competent cells, and the recombinant bacmid containing the bee venom signal peptide and IBDV VP2 is obtained by blue-white screening and PCR identification. The recombinant bacmid is transfected into sf9 cells, and the recombinant baculovirus is constructed after transposition. The recombinant baculovirus infects sf9, and the expressed recombinant protein is identified by SDS-PAGE and Western-blot. The recombinant VP2 protein is purified by nickel column affinity chromatography. As a result, the target protein is secreted and expressed, and the expression level of VP2 protein is increased. The VP2 protein is coated on a chemiluminescent plate, and the biological activity of the recombinant VP2 protein is detected by chemiluminescent enzyme-linked immunosorbent assay. The results show that the sensitivity and specificity of the recombinant VP2 protein are good.

[0039] (3) The serum diluent was phosphate buffer containing 5% (v / v) casein and 0.5% (v / v) Tween-20, pH = 7.4.

[0040] (4) Luminescent substrate A contains 0.1 mmol / L luminol and 0.01% hydroxycoumarin by volume; the solvent is 0.05 mol / L Tris buffer at pH = 8.0;

[0041] (5) Luminescent substrate B contains 0.07 mmol / L vitamin C and 3 mmol / L amino acid oxidase, and the solvent is 0.05 mol / L ammonium acetate solution with a pH of 5.2.

[0042] (6) The 10-fold concentrated washing solution is 0.02 mol / L sodium dihydrogen phosphate, 0.08 mol / L sodium dihydrogen phosphate, 1.37 mol / L sodium chloride and 0.5% (v / v) Tween-20, pH = 7.4.

[0043] This embodiment also provides a method for detecting using the chicken infectious bursal virus chemiluminescent ELISA antibody detection kit, and the detection steps are as follows:

[0044] The serum to be tested was diluted 1:100 times with serum diluent, and 100uL was added to the chemiluminescent antigen coated plate, and the positive control serum and negative control serum of infectious bursal disease were set as controls. The chemiluminescent antigen coated plate was reacted at 37°C for 15 minutes; washed 5 times with washing solution, and goat anti-chicken IgG antibody labeled with horseradish peroxidase diluted 10,000 times with 5% BSA-PBST was added, and incubated at 37°C for 15 minutes; washed 5 times with washing solution, luminescent substrate A and luminescent substrate B were added, reacted at 15-25°C for 5 minutes, and the luminescence value was detected with a chemiluminescent immunoassay detection instrument.

[0045] Example 2

[0046] Establishment of the chemiluminescent ELISA antibody detection kit for chicken infectious bursal virus:

[0047] The optimal coating concentration and the dilution multiple of goat anti-chicken IgG labeled with horseradish peroxidase were determined by the chessboard titration method. The VP2 protein was diluted in a gradient of 2ug / ml, 1ug / ml, 0.5ug / ml, 0.25ug / ml and 0.1ug / ml, and the infectious bursal positive control and negative control sera were diluted 1:100 times, respectively. The enzyme-labeled antibody dilution multiples were 1:1000, 1:2000, 1:5000, 1:10000, and 1:20000. Through chessboard cross detection, according to the signal-to-noise ratio of the positive control and the negative control, the final coating condition was determined to be a VP2 protein coating concentration of 1ug / ml. The dilution multiple of the goat anti-chicken IgG antibody labeled with horseradish peroxidase was 1:10000.

[0048] Example 3

[0049] The critical value of the chicken infectious bursal virus chemiluminescent ELISA antibody detection kit is determined by using the kit of the present invention to detect serum with a known background.

[0050] The kit was used to detect 60 positive samples of infectious bursal disease in chickens and 180 negative samples, and the S / P value of each sample was calculated. The S / P value of all serum samples was analyzed using SPSS16.0 software. The ROC curve was constructed using a non-parametric method, and the cut-off point with the maximum Youden index was used as the critical point for positive and negative judgment. The sensitivity and specificity of the kit were also determined. Finally, the judgment standard of this kit was set as: S / P value <0.45, the sample was judged as antibody negative; S / P value ≥0.45, the sample was judged as chicken infectious bursal disease antibody positive. Under this judgment standard, the sensitivity of chicken infectious bursal disease antibody detection corresponding to the critical value was 96.22%, and the specificity was 93.16%, which proved that the accuracy of this diagnostic method was high and the kit had a high diagnostic value.

[0051] Example 4

[0052] Chicken infectious bursal virus chemiluminescent ELISA antibody detection kit sensitivity and specificity detection:

[0053] The positive serum of infectious bursal disease of chicken was diluted with serum diluent in multiple ratios, and the gradients were 1:32, 1:64, 1:128, 1:256, 1:512, 1:1024, 1:2048, and the diluted samples were directly tested. The positive serum of avian influenza virus H9 subtype, Haemophilus paragallinarum, avian leukosis, infectious bronchitis and Newcastle disease virus were diluted 1:100 times, and the diluted samples were directly tested. At the same time, positive control serum and negative control serum were set as controls. The diluted sample is added to the chemiluminescent antigen coated plate, reacted at 37°C for 15 minutes; washed with a washing solution for 5 times, and a goat anti-chicken IgG antibody labeled with horseradish peroxidase diluted 10,000 times with 5% BSA-PBST is added, and incubated at 37°C for 15 minutes; washed with a washing solution for 5 times, luminescent substrate A and luminescent substrate B are added, reacted at 15-25°C for 5 minutes, and the luminescence value is detected by a chemiluminescent immunoassay detection instrument. The detection result is evaluated by the S / P value, and the S / P formula is as follows: S / P=(detection sample luminescence value-negative control serum sample luminescence value) / (positive control serum sample luminescence value-negative control serum sample luminescence value). Result The chicken infectious bursal chemiluminescent ELISA antibody detection kit of the present invention has good sensitivity, and the dilution of detecting chicken infectious bursal can reach 1:1024. The chicken infectious bursal chemiluminescent ELISA antibody detection kit of the present invention has good specificity, and has no cross reaction with the above-mentioned avian influenza virus H9 subtype positive serum, Haemophilus paragallinarum positive serum, avian leukosis positive serum, chicken infectious bronchitis positive serum and chicken Newcastle disease virus positive serum. Therefore, the chemiluminescent kit of the present invention has high sensitivity and strong specificity. The specific results are shown in Table 1.

[0054] Table 1 Sensitivity and specificity results

[0055]

[0056]

[0057] Example 5

[0058] Repeatability test of chemiluminescent ELISA antibody test kit for chicken infectious bursal virus:

[0059] Five positive and negative sera with clear background were repeated five times on the same chemiluminescent antigen-coated plate, and the intra-batch coefficient of variation (CV) was calculated. At the same time, the five sera with clear background were repeated on three different batches of chemiluminescent antigen-coated plates, and the inter-batch coefficient of variation (CV) was calculated. The results showed that both the intra-batch and inter-batch CVs were less than 10%, with good repeatability. The specific results are shown in Table 2.

[0060] Table 2 Repeatability results

[0061]

[0062] Example 6

[0063] Stability test of chemiluminescent ELISA antibody detection kit for chicken infectious bursal virus:

[0064] In order to test the stability and shelf life of the kit, the kit was placed at 2-8°C and taken out at 1, 3, 6, 9, 12 and 15 months for sensitivity and specificity tests. The results showed that at the 15th month, the sensitivity and specificity test results of the kit were normal. Therefore, the kit can be stably stored at 2-8°C for 15 months, and the chemiluminescence kit has good stability.

[0065] Example 7

[0066] Comparison of the test results of the chicken infectious bursal disease virus chemiluminescent ELISA antibody test kit and the commercial avian infectious bursal disease virus antibody ELISA test kit (IDEXX Laboratories, Inc. product code: 99-09260) on samples with known chicken infectious bursal disease virus antibody positive:

[0067] The 60 known antibody positive samples collected were tested with the chicken infectious bursal disease virus chemiluminescent ELISA antibody detection kit and the commercial avian infectious bursal disease virus antibody ELISA detection kit, and the results showed that the chemiluminescent kit detected all of them, and the commercial avian infectious bursal disease virus antibody ELISA detection kit detected 47 antibody positive samples. The detection rate of the chemiluminescent kit for positive samples was higher than that of the commercial avian infectious bursal disease virus antibody ELISA detection kit. The specific results are shown in Table 3.

[0068] Table 3 Test results of known positive samples

[0069]

[0070]

[0071]

[0072] Example 8

[0073] Comparison of the sensitivity of the chicken infectious bursal disease virus chemiluminescent ELISA antibody detection kit and the commercial avian infectious bursal disease virus antibody ELISA detection kit (IDEXX Laboratories, Inc. product code: 99-09260) to chicken infectious bursal disease antibody positive serum:

[0074] The chicken infectious bursal disease positive serum was diluted with serum diluent in multiple ratios, and the gradients were 1:32, 1:64, 1:128, 1:256, 1:512, 1:1024, and 1:2048. The samples of each dilution were detected by the chicken infectious bursal disease virus chemiluminescent ELISA antibody detection kit and the commercial avian infectious bursal disease virus antibody ELISA detection kit. Results The sensitivity of the chemiluminescent kit to detect chicken infectious bursal disease antibodies can reach 1:1024, and the sensitivity of the commercial avian infectious bursal disease virus antibody ELISA detection kit to detect chicken infectious bursal disease antibody positive serum can reach 1:512, and the chemiluminescent kit has higher sensitivity. The specific results are shown in Table 4.

[0075] Table 4 Sensitivity comparison results

[0076] Sample name Results of the experimental group Results of the control group Chicken infectious bursal disease virus positive serum 1:32 Positive Positive Chicken infectious bursal disease virus positive serum 1:64 Positive Positive Chicken infectious bursal disease virus positive serum 1:128 Positive Positive Chicken infectious bursal disease virus positive serum 1:256 Positive Positive Chicken infectious bursal disease virus positive serum 1:512 Positive Positive Chicken infectious bursal disease virus positive serum 1:1024 Positive Negative Chicken infectious bursal disease virus positive serum 1:2048 Negative Negative

[0077] The above-mentioned embodiments only express several implementation methods of the present invention, which is convenient for understanding the technical solution of the present invention in detail, but it cannot be understood as limiting the scope of the invention patent protection. It should be pointed out that for ordinary technicians in this field, several modifications and improvements can be made without departing from the concept of the present invention, which all belong to the protection scope of the present invention.

Claims

1. A detection kit, characterized in that: The invention comprises a coating solution, an antigen coating plate, an enzyme-labeled secondary antibody, a sample diluent, a positive control serum, a negative control serum, a luminescent substrate and a washing solution; the coating solution is based on a carbonate buffer solution with a pH value of 9.2-9.8, and the added antigen is a HMB-VP2 recombinant protein at a concentration of 0.9-1.1 μg / ml; the HMB-VP2 recombinant protein is expressed by SEQ ID The gene expression of the nucleotide sequence shown in NO.1 is obtained; the enzyme-labeled secondary antibody is a goat anti-chicken IgG antibody labeled with horseradish peroxidase, and the dilution multiple is 1:10000; the sample diluent is a phosphate buffer containing casein and Tween-20; based on the volume of the phosphate buffer as 100vol%, the casein content is 4-6vol%, and the Tween-20 content is 0.4-0.6vol%; the luminescent substrate includes a luminescent substrate A and a luminescent substrate B; the luminescent substrate A is based on a Tris buffer with a pH value of 7.5-8.5 and a concentration of 0.04-0.06mol / L, and 0.08-0.12mmol / L of Rutin is added Minoxidil and 0.08-0.12g / L hydroxycoumarin; the luminescent substrate B is based on an ammonium acetate solution with a pH value of 5.0-5.5 and a concentration of 0.04-0.06mol / L, and is added with 0.06-0.08mmol / L vitamin C and 2.7-3.3mmol / L amino acid oxidase; the washing solution, based on a 10-fold concentration, includes 0.018-0.022mol / L sodium dihydrogen phosphate, 0.07-0.09mol / L sodium hydrogen phosphate, 1.29-1.45mol / L sodium chloride and 0.4-0.6vol% Tween-20; the washing solution, based on a 10-fold concentration, has a pH value of 7.3-7.

5.

2. Use of the detection kit according to claim 1 in the detection of infectious bursal virus of chickens for non-disease diagnosis purposes, characterized in that: The application includes detecting whether chicken infectious bursal disease virus is present in vaccine products, blood products or poultry processed products.

3. The application according to claim 2, characterized in that: The steps include: S1. After the sample is diluted with sample diluent, it is added to the coated plate for reaction; S2, washing the coated plate after the reaction in step S1 with a washing solution, adding an enzyme-labeled secondary antibody, and incubating; S3, washing the coated plate after incubation in step S2 with a washing solution, adding a luminescent substrate, and detecting the luminescence value using a chemiluminescent immunoassay detection instrument; S4, judging whether the test sample contains infectious bursal virus of chicken according to the luminescence value obtained in step S3; The determination method in step S4 includes: The S / P value was calculated according to the formula: S / P value = (luminescence value of the test sample - luminescence value of the negative control serum sample) / (luminescence value of the positive control serum sample - luminescence value of the negative control serum sample); If the S / P value is less than 0.45, it is determined that the sample does not contain infectious bursal disease virus; If the S / P value is ≥0.45, it is determined that the sample contains infectious bursal virus.